Finance Hone Health Gets $228M to Expand Longevity Platform ATN Staff Published: November 18, 2026 Share on Facebook Share on Twitter Share via Email credit: Hone Health Subscribe Now Log in The longevity platform plans to expand its physician-led care, AI technology and diagnostics offerings as it pushes further into preventive healthcare Hone Health has raised $228 million in financing led by MarcyPen Capital Partners, the investment firm co-founded by Jay-Z, as the longevity platform looks to expand its physician-led care offerings and AI-powered technology. The financing includes $28 million in equity and $200 million in growth financing from General Catalyst’s Customer Value Fund. MarcyPen, which previously led Hone’s Series A financing, was joined by investors including Pentland Ventures and Kinship Ventures, the investment firm co-founded by Gwyneth Paltrow. Hospitality entrepreneur David Grutman has also joined Hone Health as a strategic investor and adviser, bringing a group of celebrity investors that includes Nick, Joe and Kevin Jonas, comedian Marcello Hernández and singer Kelly Rowland. The financing brings Hone’s total equity funding to $65 million. Founded in 2020 by CEO Saad Alam, Hone initially focused on testosterone and hormone optimization before expanding into broader longevity care, including weight management, cardiovascular health and menopause treatment. The company has treated more than 200,000 patients and administered over 750,000 tests, according to its latest figures. Hone plans to use the new funding to expand into metabolic health, inflammation and immune health, while integrating additional diagnostics such as full-body MRI, DEXA scans and coronary CT angiography. The company will also invest in its proprietary AI platform, Longevity OS, which combines patient health data, lab results and treatment history to help physicians develop personalized care plans. Other priorities include physician-supervised peptide therapies and clinical research. “Today, consumers have almost limitless options when it comes to preventative health, but what people are looking for is the highest level of insight into their metrics,” Alam said. “Hone combines comprehensive diagnostic testing, physician-led care, and AI-powered insights to deliver that level of understanding.” credit: Hone Health Alongside the funding, Hone is publicly launching Hone Black, a concierge longevity membership that has operated privately for the past year. The program combines testing across more than 1,600 health markers with ongoing care from a dedicated physician team. Treatment options include prescription medications, supplements, peptides and other therapies. The announcement follows Hone’s $33 million Series A, disclosed in January 2025, which supported its expansion beyond hormone optimization and included the acquisition of in-home care platform ivee. The longevity platform plans to expand its physician-led care, AI technology and diagnostics offerings as it pushes further into preventive healthcare Hone Health has raised... Membership Required This article is for ATN Pro members only. Subscribe Now Already a member? Log in Already a member? Log in here